Subscribe: Market Wire - Medical and Healthcare: Medical Devices
Added By: Feedage Forager Feedage Grade B rated
Language: English
announces  company  december  healthcare  hong kong  hong  kong  marketwired december  marketwired  medical  regenerative medicine 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices

Marketwired - Medical Devices

Last Build Date: Thu, 07 Dec 2017 10:14:03 EST

Copyright: Copyright: (C) Marketwired

UltraSPECT's New Ultra-Secured Gateway Delivers Impenetrable Defense Against Cybercriminals Seeking to Breach Nuke Med Systems

Thu, 07 Dec 2017 09:43:53 EST

Military-grade 'USG' gateway ensures airtight data security for users of UltraSPECT's popular image-reconstruction solution

Lexington Hires Medical Device Reimbursement Experts

Thu, 07 Dec 2017 09:00:00 EST

Company engages Navigant Consulting to formulate strategy for coverage policy

IEC Announces Fiscal 2017 Fourth Quarter and Year End Results

Wed, 06 Dec 2017 08:30:00 EST

NEWARK, NY--(Marketwired - December 06, 2017) - IEC Electronics Corp. (NYSE American: IEC) today announced results for the fiscal 2017 fourth quarter and year ended September 30, 2017.

Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7

Wed, 06 Dec 2017 07:00:00 EST

MONTREAL, QUEBEC--(Marketwired - Dec. 6, 2017) - Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the signing of an exclusive distribution agreement (the "Agreement") with Tersus Life Sciences for Provinal® C16:1n7 a patented, ultra-purified Omega 7 fatty acid blend .

New Aurora Advanced Flow Cytometry System from Cytek Biosciences Resonates with Researchers Around the World

Tue, 05 Dec 2017 10:00:00 EST

Systems Purchased by Laboratories on Four Continents -- and Counting

Vaxil Strengthens Board of Directors and Management Concurrent to $1-Million Financing

Tue, 05 Dec 2017 08:30:00 EST

NESS-ZIONA, ISRAEL--(Marketwired - December 05, 2017) - VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative Israeli immuno-oncology biotechnology company, is pleased to announce the addition of two veteran healthcare executives to its Board of Directors. Dr. Ari Kellen, formerly of McKinsey & Company, Bausch + Lomb, and Valeant; together with Dr. Shawn Langer, formerly of McKinsey & Company, and a current healthcare private equity portfolio manager with BMHS Investments, have joined Vaxil's Board of Directors. Director Mr. Isaac Maresky, an investment banking professional with hundreds of millions of dollars of financings and M&A experience, including co-founding another successful immunotherapy company, has been appointed CEO of Vaxil.

NanoVibronix Announces Exclusive UK Distributor for PainShield(TM) Providing Patients an Alternative to Opioids and Surgery

Tue, 05 Dec 2017 08:00:00 EST

ELMSFORD, NY--(Marketwired - December 05, 2017) - NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed BHR Pharmaceuticals Ltd., a leading distributor of medical and diagnostic devices to both consumers and healthcare professionals, as its exclusive distributor for PainShieldT in the United Kingdom.

National Leader Children's Hospital Colorado to Adopt Milestone Scientific's The Wand(R) STA(R) as Exclusive Instrument For Pediatric Dental Injections

Tue, 05 Dec 2017 07:30:00 EST

Provides children "the most comfortable, safest and stress-free experience"

Taiwan Healthcare Experts Share Medical Excellence on Malaysian Patients

Mon, 04 Dec 2017 23:19:43 EST

Team introduces advanced medical services and welcomes Malaysian health industries for investment and collaboration

Rennova Health Announces That Big South Fork Medical Center Has Received Its First Payments for Services Provided

Mon, 04 Dec 2017 09:20:00 EST

WEST PALM BEACH, FL--(Marketwired - December 04, 2017) - Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that on Friday, December 1, 2017, Big South Fork Medical Center ("BSFMC") started receiving payments from private insurers for services provided since its opening on August 8, 2017.

Looking Beyond Risk in Risk-Based Monitoring, New Webinar Hosted by Xtalks

Mon, 04 Dec 2017 07:30:00 EST

Fourth in the series Four Steps to Shorten Your Clinical Trials with Informatics

MetLife Hong Kong Sponsors Pink Heels Race 2017 to Support Awareness of Hereditary Cancer

Mon, 04 Dec 2017 01:48:12 EST

HONG KONG, CHINA--(Marketwired - Dec 4, 2017) - MetLife Hong Kong* sponsored the Hong Kong Hereditary Breast Cancer Family Registry's seventh annual Pink Heels Race to promote hereditary cancer awareness. In addition to sponsoring the event, MetLife Hong Kong had over 40 employees and agents onsite to participate in the Pink Heels Race.

Xtalks Announces its Webinars for December 2017

Fri, 01 Dec 2017 07:30:00 EST

TORONTO, ON--(Marketwired - December 01, 2017) - Upcoming free, educational webinars from Xtalks Webinars will feature topics on clinical trials, clinical supply chain, drug discovery & development, drug safety, laboratory technology and medical devices.

Fresenius Medical Care achieves a milestone in expanding its Asian operations

Thu, 30 Nov 2017 20:53:25 EST

QUANZHOU, CHINA--(Marketwired - Nov 30, 2017) - Fresenius Medical Care (FME), the global market leader in dialysis, launched last week in Quanzhou its first independent dialysis center in China.

The Alliance for Regenerative Medicine Announces 2018 Cell & Gene Therapies State of the Industry Briefing

Thu, 30 Nov 2017 11:42:16 EST

WASHINGTON, DC--(Marketwired - Nov 30, 2017) -  The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapies and broader regenerative medicine sector, announced its 2018 Cell & Gene Therapies State of the Industry briefing will take place January 8, 2018 in San Francisco, held in conjunction with Biotech ShowcaseT 2018.